GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • October 25th, 2013 • Galectin Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 25th, 2013 Company Industry JurisdictionGalectin Therapeutics Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: